Cargando…
Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 – Authors' reply
Autores principales: | Bovijn, Jonas, Lindgren, Cecilia M, Holmes, Michael V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836692/ https://www.ncbi.nlm.nih.gov/pubmed/33521676 http://dx.doi.org/10.1016/S2665-9913(20)30415-X |
Ejemplares similares
-
Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19
por: Bovijn, Jonas, et al.
Publicado: (2020) -
Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19
por: Garbers, Christoph, et al.
Publicado: (2021) -
Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2021) -
Systemic IL-6 and Severe Asthma
por: Lipworth, Brian, et al.
Publicado: (2020) -
Role of IL-6 in Severe Inflammation
por: Inoue, Ken-ichiro, et al.
Publicado: (2021)